Unknown

Dataset Information

0

Effects of the enhanced public health intervention during the COVID-19 epidemic on respiratory and gastrointestinal infectious diseases in China.


ABSTRACT: The public health interventions to mitigate coronavirus disease 2019 (COVID-19) could also potentially reduce the global activity of influenza. However, this strategy's impact on other common infectious diseases is unknown. We collected data of 10 respiratory infectious (RI) diseases, influenza-like illnesses (ILIs), and seven gastrointestinal infectious (GI) diseases during 2015-2020 in China and applied two proportional tests to check the differences in the yearly incidence and mortality, and case-fatality rates (CFRs) over the years 2015-2020. The results showed that the overall RI activity decreased by 7.47%, from 181.64 in 2015-2019 to 168.08 per 100 000 in 2020 (p < 0.001); however, the incidence of influenza was seen to have a 16.08% escalation (p < 0.001). In contrast, the average weekly ILI percentage and positive influenza virus rate decreased by 6.25% and 61.94%, respectively, in 2020 compared to the previous 5 years (all p < 0.001). The overall incidence of GI decreased by 45.28%, from 253.73 in 2015-2019 to 138.84 in 2020 per 100 000 (p < 0.001), and with the greatest decline seen in hand, foot, and mouth disease (HFMD) (64.66%; p < 0.001). The mortality and CFRs from RI increased by 128.49% and 146.95%, respectively, in 2020, compared to 2015-2019 (p < 0.001). However, the mortality rates and CFRs of seven GI decreased by 70.56% and 46.12%, respectively (p < 0.001). In conclusion, China's COVID-19 elimination/containment strategy is very effective in reducing the incidence rates of RI and GI, and ILI activity, as well as the mortality and CFRs of GI diseases.

SUBMITTER: Wang L 

PROVIDER: S-EPMC9015532 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Effects of the enhanced public health intervention during the COVID-19 epidemic on respiratory and gastrointestinal infectious diseases in China.

Wang Lan L   Guo Xiangyu X   Zhao Na N   Ouyang Yanyan Y   Du Binghui B   Xu Wangli W   Chan Ta-Chien TC   Jiang Hui H   Liu Shelan S  

Journal of medical virology 20220204 5


The public health interventions to mitigate coronavirus disease 2019 (COVID-19) could also potentially reduce the global activity of influenza. However, this strategy's impact on other common infectious diseases is unknown. We collected data of 10 respiratory infectious (RI) diseases, influenza-like illnesses (ILIs), and seven gastrointestinal infectious (GI) diseases during 2015-2020 in China and applied two proportional tests to check the differences in the yearly incidence and mortality, and  ...[more]

Similar Datasets

| S-EPMC8631357 | biostudies-literature
| S-EPMC7177391 | biostudies-literature
| S-EPMC9771282 | biostudies-literature
| S-EPMC8107544 | biostudies-literature
| S-EPMC8484818 | biostudies-literature
| S-EPMC8285224 | biostudies-literature
| S-EPMC6925075 | biostudies-literature
| S-EPMC9065650 | biostudies-literature
| S-EPMC11390917 | biostudies-literature
| S-EPMC8390098 | biostudies-literature